Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
BNT162b2 Vaccine
100%
Kidney Transplant
100%
Dialysis Patients
100%
Chronic Dialysis Patients
100%
Tozinameran
100%
Vaccination
75%
Kidney Transplant Recipients
75%
COVID-19
50%
Antibody Level
50%
Antibody Response
50%
Infection Rate
25%
Hypertension
25%
Risk Assessment
25%
Humoral Response
25%
Old Age
25%
Cancer History
25%
Calcineurin Inhibitors
25%
MTOR Inhibitor
25%
BNT162b2
25%
Risk Change
25%
Hemodialysis
25%
Healthcare Team
25%
Drug Levels
25%
MRNA Vaccine
25%
Subsequent Infection
25%
IgG Antibody
25%
Non-response
25%
Transplant Patients
25%
Lymphocyte Count
25%
Low Vitamin D
25%
Serum Ferritin
25%
Vaccination Policy
25%
Inhibitor Drug
25%
Reduced Antibodies
25%
Chronic Renal Replacement Therapy
25%
Outpatient Dialysis
25%
Humoral Immunogenicity
25%
Medicine and Dentistry
Infection
100%
Kidney Graft
100%
mRNA Vaccine
100%
COVID-19
50%
Antibody Response
50%
Diabetes
25%
Outpatient
25%
Malignant Neoplasm
25%
Cohort Analysis
25%
Renal Replacement Therapy
25%
Messenger RNA
25%
Infection Rate
25%
Lymphocyte
25%
Humoral Immunity
25%
Vitamin D
25%
Immunoglobulin G
25%
Calcineurin Inhibitor
25%
Mammalian Target of Rapamycin Inhibitor
25%
Ferritin
25%
Hemodialysis
25%
Immunogenicity
25%